Fasting Cycles Potentiate the Efficacy of Gemcitabine Treatment in in Vitro and in Vivo Pancreatic Cancer Models

Oncotarget - United States
doi 10.18632/oncotarget.4186
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

In Vitro and in Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2′-Deoxy-2′-Fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer Models

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2017English

Curaxin CBL0137 Eradicates Drug Resistant Cancer Stem Cells and Potentiates Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer

Oncotarget
Oncology
2014English

Novel Gemcitabine Conjugated Albumin Nanoparticles: A Potential Strategy to Enhance Drug Efficacy in Pancreatic Cancer Treatment

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2017English

The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1)

Clinical Cancer Research
Cancer ResearchOncology
2015English

In Vitro and in Vivo Efficacy of Afatinib as a Single Agent or in Combination With Gemcitabine for The treatment of Nasopharyngeal Carcinoma

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-Regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase

Cancer Research
Cancer ResearchOncology
2009English

Emodin Reverses Gemcitabine Resistance in Pancreatic Cancer Cells via the Mitochondrial Apoptosis Pathway in Vitro

International Journal of Oncology
Cancer ResearchOncology
2011English

Outcomes of Gemcitabine Treatment for Invasive Ductal Pancreatic Cancer

Suizo
2007English

FKBP5 as a Selection Biomarker for Gemcitabine and Akt Inhibitors in Treatment of Pancreatic Cancer

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy